Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers [Phase 1]
Phase 1 study evaluating the effects of GSK573719 alone and in combination with vilanterol (VI) in adults with moderate hepatic impairment a…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment [Phase 1]
A Phase 1 study evaluating the safety and pharmacokinetics of GSK573719 alone and in combination with GW642444(VI) in healthy subjects and t…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD) [NA]
This entry reports the completion and posted results of a clinical trial evaluating nitric oxide bioavailability in chronic obstructive pulm…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Healthy Volunteer Study With Inhaled GSK573719 and Placebo [Phase 1]
Phase 1 healthy volunteer study of inhaled GSK573719 versus placebo has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer [NA]
This ClinicalTrials.gov entry reports a completed study evaluating lung rehabilitation in COPD patients undergoing surgery for lung cancer. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of inhaled GSK233705 and GW642444 in healthy subjects. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole [Phase 1]
This Phase 1 trial update reports the completion of a drug interaction study evaluating co-administration of GW642444M with ketoconazole in …
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics of single and repeat doses of the dry powder formulation of GSK2269557 in…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
Phase 2 trial evaluating safety, tolerability, pharmacokinetics, and dose-response of multiple doses of GSK2269557 dry powder in COPD patien…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations [Phase 4]
Phase 4 trial update evaluating the effects of indacaterol in symptomatic chronic obstructive pulmonary disease patients at low risk of exac…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]
Phase 1 clinical trial update evaluating prednisolone with a novel endpoint in patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old [Phase 1]
Phase 1 study assessing blood levels and physiological effects of GSK1325756 in healthy adults aged 40-80 years.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Theophylline in Chronic Obstructive Pulmonary Disease [Phase 2, Phase 3]
The clinical trial update indicates that theophylline trials in chronic obstructive pulmonary disease have completed Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers [Phase 1]
Phase 1 study sponsored by GlaxoSmithKline to assess the effects of SRT2104 and prednisolone on blood biomarkers in healthy volunteers; chro…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers [Phase 3]
Phase 3 trial comparing smoking cessation strategies to long-term nicotine replacement in high-risk smokers; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 [Phase 2]
A Phase 2 escalating and cumulative-dose PK/PD and safety study of the investigational drug A006 by Amphastar Pharmaceuticals has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
The Temple University–sponsored clinical trial evaluating chronic obstructive pulmonary disease exacerbations has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese Subjects [Phase 1]
This Phase 1 trial evaluated the safety, tolerability, and pharmacokinetic/pharmacodynamic effects of GSK573719 (LAMA) and GW642444 (LABA) w…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Helium-3 MRI Imaging Study in COPD [Phase 1]
Phase 1 trial evaluating helium-3 MRI imaging for assessing lung ventilation in chronic obstructive pulmonary disease has completed. Sponsor…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: GSK573719 IV Enabling Study [Phase 1]
Phase 1 enabling study of GSK573719 IV in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients [Phase 1]
Phase 1 study evaluating lung deposition of a triple inhaled therapy (beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide)…
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis [NA]
A completed clinical trial evaluated the sustained effects of inhaled hypertonic saline on mucociliary clearance in people with chronic bron…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Post Marketing Surveillance of Roflumilast in Korea
Completed post-marketing surveillance study of roflumilast in Korea for chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial updating preference attributes of ELLIPTA and HANDIHALER dry powder inhalers in COPD patients; results completed with posted r…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444. [Phase 1]
Phase 1 trial evaluating excretion, balance, and metabolic disposition of radiolabeled GW642444 after a single dose in chronic obstructive p…